Treatment Regimen for Efudex (Fluorouracil) in Actinic Keratosis and Superficial Basal Cell Carcinoma
For actinic keratosis, Efudex (5-fluorouracil) 5% cream should be applied twice daily for 2-4 weeks, while for superficial basal cell carcinoma, it should be applied twice daily for 3-12 weeks until the lesions are obliterated. 1
Actinic Keratosis Treatment
Dosing Regimen
5% Fluorouracil (Efudex) cream:
0.5% Fluorouracil cream (alternative option):
Treatment Approach Based on Lesion Presentation
For multiple lesions or field cancerization:
For few discrete lesions:
Superficial Basal Cell Carcinoma Treatment
Dosing Regimen
- Only 5% strength is recommended 1
- Apply twice daily in an amount sufficient to cover the lesions 1
- Treatment duration:
Efficacy and Follow-up
- Success rate with 5-FU cream is approximately 93% for basal cell carcinomas 1
- Histologic cure rate of 90% has been demonstrated in clinical studies 6
- Follow-up is essential to determine if cure has been obtained 1
Application Instructions
- Apply cream with a non-metal applicator or suitable glove 1
- If applied with fingers, wash hands immediately afterward 1
- Apply sufficient amount to cover the lesions completely 1
Expected Treatment Response
Treatment response follows this sequence:
- Erythema
- Vesiculation
- Desquamation
- Erosion
- Re-epithelialization 1
Managing Side Effects
- Common side effects include soreness, redness, and crusting 3
- Side effects can be minimized through:
- Reduction in frequency of application
- Short breaks during treatment course
- Application of emollients
- In severe cases, topical steroids may be used 2
Important Considerations
- Inflammation appears necessary for treatment efficacy 7
- Daily application is more effective than weekly application 7
- For resistant lesions, consider combination therapy with cryosurgery 5
- Biopsy is indicated for lesions that fail to respond to appropriate therapy 3
Treatment Limitations
- For isolated, easily accessible basal cell carcinomas, surgery is preferred (nearly 100% success rate) 1
- 5-FU has not been proven effective for other types of basal cell carcinomas 1
- Treatment should be avoided in periocular areas 3
- Use with caution on poor healing sites such as the lower leg 2
Following this treatment regimen will maximize efficacy while managing side effects appropriately for both actinic keratosis and superficial basal cell carcinoma.